Physical Therapy Intervention in Post Polio Syndrome: Difference between revisions

(Newer references)
(changed reference for diagnosis)
Line 27: Line 27:


== Diagnosis ==
== Diagnosis ==
There is no definitive laboratory test for diagnosing PPS  and symptoms can often mimic other neurological conditions; exclusion of these and other possible skeletal conditions is the first step in moving towards a diagnosis of PPS.  Once other pathologies have been excluded the following criteria can be used to confirm PPS<ref name=":5" />:
Diagnosis of PPS is currently based on March of Dimes, a modified version of the Halstead criteria. It includes:  
# Prior paralytic poliomyelitis with evidence of motor neuron loss, as confirmed by history of the acute paralytic illness, signs of residual weakness and atrophy of muscles on neuromuscular examination, and signs of nerve damage on electromyography (EMG). Rarely, persons have subclinical paralytic polio, described as a loss of motor neurons during acute polio but with no obvious deficit. That prior polio now needs to be confirmed with an EMG. Also, a reported history of nonparalytic polio may be inaccurate.
# Prior paralytic poliomyelitis with evidence of motor neuron loss, as confirmed by history of the acute paralytic illness, signs of residual weakness and atrophy of muscles on neuromuscular examination, and signs of nerve damage on electromyography (EMG). Rarely, persons have subclinical paralytic polio, described as a loss of motor neurons during acute polio but with no obvious deficit. That prior polio now needs to be confirmed with an EMG. Also, a reported history of nonparalytic polio may be inaccurate.
# A period of partial or complete functional recovery after acute paralytic poliomyelitis, followed by an interval (usually 15 years or more) of stable neuromuscular function.
# A period of partial or complete functional recovery after acute paralytic poliomyelitis, followed by an interval (usually 15 years or more) of stable neuromuscular function.
# Gradual onset of progressive and persistent new muscle weakness or abnormal muscle fatigability (decreased endurance), with or without generalized fatigue, muscle atrophy, or muscle and joint pain. Onset may at times follow trauma, surgery, or a period of inactivity, and can appear to be sudden. Less commonly, symptoms attributed to post-polio syndrome include new problems with breathing or swallowing.
# Gradual onset of progressive and persistent new muscle weakness or abnormal muscle fatigability (decreased endurance), with or without generalized fatigue, muscle atrophy, or muscle and joint pain. Onset may at times follow trauma, surgery, or a period of inactivity, and can appear to be sudden. Less commonly, symptoms attributed to post-polio syndrome include new problems with breathing or swallowing.
# Symptoms that are present for at least a year
# Symptoms that are present for at least a year.
# Exclusion of other neurologic, medical, and orthopeadic problems as causes of symptoms
<ref>Sáinz MP, Pelayo R, Laxe S, Castaño B, Capdevilla E, Portell E. [https://www.elsevier.es/en-revista-neurologia-english-edition--495-articulo-describing-post-polio-syndrome-S2173580821000614 Describing post-polio syndrome.] Neurología (English Edition). 2022 Jun 1;37(5):346-54.</ref>


== Physical Therapy Management ==
== Physical Therapy Management ==

Revision as of 13:17, 19 November 2023

This article is currently under review and may not be up to date. Please come back soon to see the finished work! (19/11/2023)

What is Polio?[edit | edit source]

Poliomyelitis, also commonly known as polio, is a disease that mainly affects children below the age of 5. It is a highly infectious disease and spreads from person-person through the feacal-oral route or contaminated food and water[1]. It is caused by the group C enterovirus known as Poliovirus (PV). PV mainly grows in the GI tract and can multiply and further spread to other parts of the body including nervous tissue. Upon spreading to the Central Nervous System, the virus targets motor neurons which results in its classical clinical presentation[2]. The main symptoms of Poliomyelitis include:

  • Fever
  • General discomfort
  • Severe limb pain
  • Flaccid paralysis
  • Myalgia
  • Fatigue
  • Nausea

[3][4]

Polio is not a new disease and was in fact first reported in England, by Michael Underwood, in 1789. He described cases of children who displayed weakness and paralysis of their lower extremities[5]. Epidemics of poliomyelitis were first observed in Scandinavia, Western Europe, and the United States towards the end of the 19th century and steadily grew in frequency and magnitude until the late 1950s and 1960s when the poliovirus vaccine was introduced[6]. A vaccine first developed by Jonas E. Salk, using killed or inactivated poliovirus (IPV), was made available by injection in 1955. The introduction of the trivalent Sabin oral vaccine (OPV) in 1962 was the beginning of the plan to eradicate Polio, the vaccine was affordable and easy to administer providing a cheap and readily administered vaccine[7] [8]. Currently, cases due to wild poliovirus have decreased by over 99% since 1988, from an estimated 350,000 cases in more than 125 endemic countries to just two endemic countries (as of October 2023)[1].

Post Polio Syndrome[edit | edit source]

Despite the successful vaccination project a new condition has emerged known as Post-Polio Syndrome (PPS). PPS is a condition that affects polio survivors years after recovery from an initial acute attack of the poliomyelitis virus. Post-polio syndrome is mainly characterized by new weakening in muscles that were previously affected by the polio infection and in muscles that seemingly were unaffected[9].

The cause of PPS is unknown, but it is thought that the new weakness of post-polio syndrome may be due to the degeneration of individual nerve terminals in the motor units. The poliovirus attacks specific neurons in the brainstem and the anterior horn cells of the spinal cord. In an effort to compensate for the loss of these neurons, ones that survive create new nerve terminals to the orphaned muscle fibers. The result is some recovery of movement and enlarged motor units[10][11]. Years of high use of these enlarged motor units adds stress to the neuronal cell body, which then, may not be able to maintain the metabolic demands of all the new pathways, resulting in the slow deterioration of motor units.[12] Restoration of nerve function may occur in some fibers a second time, but eventually, nerve terminals malfunction and permanent weakness occurs.[10] This hypothesis is consistent with post-polio syndrome's slow, stepwise, unpredictable course.

According to estimates by the National Center for Health Statistics, more than 440,000 polio survivors in the United States may be at risk for post-polio syndrome. Researchers are unable to establish a firm prevalence rate, but they estimate that the condition affects 25 percent to 50 percent of these survivors, but may be as high 60 percent.[13]

Clinical Features[edit | edit source]

Symptoms include slowly progressive muscle weakness, unaccustomed fatigue (both generalized and muscular), and, at times, muscle atrophy. Pain from joint degeneration and increasing skeletal deformities such as scoliosis are common. Some patients experience only minor symptoms. While less common, others may develop visible muscle atrophy, or wasting.[12][9]

Post-polio syndrome is rarely life-threatening. However, untreated respiratory muscle weakness can result in underventilation, and weakness in swallowing muscles can result in aspiration pneumonia.[14]

Diagnosis[edit | edit source]

Diagnosis of PPS is currently based on March of Dimes, a modified version of the Halstead criteria. It includes:

  1. Prior paralytic poliomyelitis with evidence of motor neuron loss, as confirmed by history of the acute paralytic illness, signs of residual weakness and atrophy of muscles on neuromuscular examination, and signs of nerve damage on electromyography (EMG). Rarely, persons have subclinical paralytic polio, described as a loss of motor neurons during acute polio but with no obvious deficit. That prior polio now needs to be confirmed with an EMG. Also, a reported history of nonparalytic polio may be inaccurate.
  2. A period of partial or complete functional recovery after acute paralytic poliomyelitis, followed by an interval (usually 15 years or more) of stable neuromuscular function.
  3. Gradual onset of progressive and persistent new muscle weakness or abnormal muscle fatigability (decreased endurance), with or without generalized fatigue, muscle atrophy, or muscle and joint pain. Onset may at times follow trauma, surgery, or a period of inactivity, and can appear to be sudden. Less commonly, symptoms attributed to post-polio syndrome include new problems with breathing or swallowing.
  4. Symptoms that are present for at least a year.
  5. Exclusion of other neurologic, medical, and orthopeadic problems as causes of symptoms

[15]

Physical Therapy Management[edit | edit source]

Physical therapy management for post-polio syndrome (PPS) involves a multidisciplinary approach to address the various symptoms and challenges faced by individuals who have survived polio. It is essential to individualize the treatment approach based on the patient's specific needs, preferences, and response to interventions. Regular reassessment and collaboration with other healthcare professionals are crucial for optimal care.

Physical Therapy Management Considerations[edit | edit source]

  • It is important to recognize the difficulty of sustaining high exercise intensities for prolonged periods, particularly in severely fatigued individuals. Training regimes must be highly individualized and exercise prescription can be based on certain individual markers such as Aerobic Threshold (AT) or Rate of Perceived Exertion (RPE).
  • Efficiently evaluate muscle function which includes endurance and strength. Understanding that improvements in muscle function may be challenging in persons with PPS due possibility of hypertrophied muscle fibers.
  • Training programmes must be tailored towards daily activities and functional independence. It should involve training muscle groups that may be disused or deconditioned and focusing on exercises that mimic daily tasks.
  • Recognize the potential limitations of exercise modes that primarily focus on the lower extremities.
  • Emphasize the importance of monitoring the actual training dose to ensure the prescribed intensities are achieved.

[16][17]

Physical Therapy Interventions[edit | edit source]

Exercise and Mobility[edit | edit source]
  • Exercise programmes must be designed to improve strength, endurance, and flexibility through low-impact activities to reduce stress on the muscles and joints.
  • Incorporate exercises that target weakened muscles with a focus on gradual progression to prevent excessive fatigue.
  • Non-fatiguing strengthening exercises such as isokinetic and isometric exercises can be included in the programme.
  • In addition to traditional exercises, aquatic therapy can also be beneficial due to its low-impact nature and the buoyancy of water providing support.[18]
Manual Therapy and Modalities[edit | edit source]
  • Appropriate strategies can be developed to manage musculoskeletal pain associated with PPS which may include manual therapy or heat/cold therapy. It is vital to collaborate with other healthcare providers to explore pharmacological interventions for pain management when necessary.[18]
  • Therapeutic ultrasound therapy and myofascial mobilization (Graston® technique) have been utilized for releasing stiffness and restoring function to affected muscles and joints. [19]
Orthotics and Assistive Devices[edit | edit source]
  • Evaluate the need for properly fitted orthoses to improve biomechanical movement patterns and conserve energy during activities. It must be ensured that orthotic devices adequately support the patient's weakened muscles and contribute to overall functional improvement.
  • Assess the need for mobility aids such as canes, crutches, walkers, or wheelchairs based on individual functional abilities and provide guidance on the selection and proper use of these assistive devices to enhance independence and reduce the risk of falls.

[18][19]

Energy Conservation Techniques[edit | edit source]
  • Energy conservation techniques can be taught to patients to reduce fatigue. Emphasize the importance of pacing physical activities to avoid overexertion. Encourage patients to plan their daily activities with sufficient rest periods to conserve energy.
  • Physiotherapists can guide patients on prioritizing tasks and utilizing assistive devices to reduce overall energy expenditure.[18]

Prevention[edit | edit source]

At present there is no treatment that can prevent or reverse Post Polio Syndrome. The quality of life of people with PPS can be improved through symptomatic management. Symptomatic management includes lifestyle modification, physiotherapy, usage of assistive devices, and pharmacological means.[20]

References[edit | edit source]

  1. 1.0 1.1 Poliomyelitis. World Health Organization. October 2023
  2. Minor P. The polio endgame. Human vaccines & immunotherapeutics. 2014 Jul 7;10(7):i-ii.
  3. Liu Q, Liu Z, Huang B, Teng Y, Li M, Peng S, Guo H, Wang M, Liang J, Zhang Y. Global trends in poliomyelitis research over the past 20 years: A bibliometric analysis. Human Vaccines & Immunotherapeutics. 2023 Dec 31;19(1):2173905
  4. Wolbert JG, Higginbotham K. Poliomyelitis. StatPearls. Treasure Island (FL).
  5. Hamborsky J, Kroger A, editors. Poliomyelitis (Chapter 18) in Epidemiology and prevention of vaccine-preventable diseases, E-Book: The Pink Book. Public Health Foundation; 2015 Oct 19.
  6. Modlin JF, Bandyopadhyay AS, Sutter R. Immunization against poliomyelitis and the challenges to worldwide poliomyelitis eradication. The Journal of infectious diseases. 2021 Oct 1;224(Supplement_4):S398-404.
  7. Biselli R, Nisini R, Lista F, Autore A, Lastilla M, De Lorenzo G, Peragallo MS, Stroffolini T, D’Amelio R. A historical review of military medical strategies for fighting infectious diseases: From battlefields to global health. Biomedicines. 2022 Aug 22;10(8):2050.
  8. Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M. Understanding modern-day vaccines: what you need to know. Annals of medicine. 2018 Feb 17;50(2):110-20.
  9. 9.0 9.1 Farbu E, Gilhus NE, Barnes MP, Borg K, De Visser M, Driessen A, Howard R, Nollet F, Opara J, Stalberg E. EFNS guideline on diagnosis and management of post‐polio syndrome. Report of an EFNS task force. European Journal of Neurology. 2006 Aug;13(8):795-801.
  10. 10.0 10.1 Trojan, D. A., & Cashman, N. R. (2004). Post-poliomyelitis syndrome. Muscle & Nerve, 31(1), 6–19.
  11. "Post-Polio Syndrome Fact Sheet", National Institute of Neurological Disorders and Stroke (NINDS), Publication date May 2012. NIH Publication No. 12-4030
  12. 12.0 12.1 Bridges, J. (2003). Post-Polio Syndrome. Journal of Consumer Health On the Internet, 7(3), 41–49. doi:10.1300/j381v07n03_05
  13. Jubelt B. Post-polio syndrome. Current treatment options in neurology. 2004 Apr;6(2):87-93.
  14. Jubelt B, Agre JC. Characteristics and management of postpolio syndrome. Jama. 2000 Jul 26;284(4):412-4.
  15. Sáinz MP, Pelayo R, Laxe S, Castaño B, Capdevilla E, Portell E. Describing post-polio syndrome. Neurología (English Edition). 2022 Jun 1;37(5):346-54.
  16. Voorn EL, Koopman FS, Brehm MA, Beelen A, De Haan A, Gerrits KH, Nollet F. Aerobic exercise training in post-polio syndrome: process evaluation of a randomized controlled trial. PLoS One. 2016 Jul 15;11(7):e0159280.
  17. Voorn EL, Koopman FS, Brehm MA, Beelen A, de Haan A, Gerrits KH, Nollet F. Correction: Aerobic Exercise Training in Post-Polio Syndrome: Process Evaluation of a Randomized Controlled Trial. Plos one. 2018 Jan 30;13(1):e0192338.
  18. 18.0 18.1 18.2 18.3 Duncan A, Batliwalla Z. Growing older with post-polio syndrome: Social and quality-of-life implications. SAGE open medicine. 2018 Aug;6:2050312118793563.
  19. 19.0 19.1 Chu EC, Lam KK. Post-poliomyelitis syndrome. International Medical Case Reports Journal. 2019 Aug 8:261-4.
  20. Post-polio syndrome. U.S. Department of Health and Human Services.